Home › Heart Attack › Virginia › Arlington
Heart Attack clinical trials in Arlington, VA
3 studies for Heart Attack are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- Nephrology Associates of Northern Virginia Inc, Fairfax · 11 mi away
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
RecruitingPhase 3
- Inova Fairfax Hospital, Falls Church · 4 mi away
- Virginia Heart, Falls Church · 4 mi away
- Carient Heart and Vascular, Manassas · 22 mi away
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RecruitingPhase 3
- Virginia Heart, Falls Church · 4 mi away
- Inova Cardiology - Fairfax, Fairfax · 11 mi away
- Carient Heart and Vascular, Manassas · 22 mi away
About Heart Attack
A heart attack happens when the blood flow to the heart gets blocked. It causes heart damage and is a medical emergency. Know the symptoms and when to call 911.
More about Heart Attack on MedlinePlus
Heart Attack trials in other cities
- Dallas, TX6 studies
- Rochester, MN6 studies
- New York City, NY6 studies
- Boston, MA5 studies
- Nashville, TN4 studies
- Detroit, MI4 studies
- Knoxville, TN4 studies
- Hartford, CT4 studies
- Houston, TX4 studies
- Boca Raton, FL4 studies
- Los Angeles, CA4 studies
- Raleigh, NC3 studies
Other studies in Arlington
- Non-Small Cell Lung Cancer104 studies
- Metastatic Cancer53 studies
- Colorectal Cancer52 studies
- Cancer (all types)49 studies
- Breast Cancer46 studies
- Ovarian Cancer45 studies
- Lung Cancer40 studies
- Endometrial Cancer38 studies
- Pancreatic Cancer34 studies
- Head and Neck Squamous Cell Carcinoma25 studies
- Small Cell Lung Cancer23 studies
- Triple-Negative Breast Cancer20 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.